Cargando…
Principles for designing an optimal mRNA lipid nanoparticle vaccine
mRNA Lipid nanoparticles (LNPs) have recently been propelled onto the center stage of therapeutic platforms due to the success of the SARS-CoV-2 mRNA LNP vaccines (mRNA-1273 and BNT162b2), with billions of mRNA vaccine doses already shipped worldwide. While mRNA vaccines seem like an overnight succe...
Autores principales: | Kon, Edo, Elia, Uri, Peer, Dan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8547895/ https://www.ncbi.nlm.nih.gov/pubmed/34715546 http://dx.doi.org/10.1016/j.copbio.2021.09.016 |
Ejemplares similares
-
Resveratrol Enhances mRNA and siRNA Lipid Nanoparticles Primary CLL Cell Transfection
por: Kon, Edo, et al.
Publicado: (2020) -
Optimization of Lipid Nanoparticles for Intramuscular Administration of mRNA Vaccines
por: Hassett, Kimberly J., et al.
Publicado: (2019) -
Principles for optimization and validation of mRNA lipid nanoparticle vaccines against COVID-19 using 3D bioprinting
por: Papi, Massimiliano, et al.
Publicado: (2022) -
From lipids to lipid nanoparticles to mRNA vaccines
por: Horejs, Christine
Publicado: (2021) -
Optimization of ionizable lipids for aerosolizable mRNA lipid nanoparticles
por: Lewis, Mae M., et al.
Publicado: (2023)